News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
378,942 Results
Type
Article (25828)
Company Profile (60)
Press Release (353054)
Section
Business (104222)
Career Advice (449)
Deals (16869)
Drug Delivery (50)
Drug Development (47561)
Employer Resources (47)
FDA (12248)
Job Trends (8431)
News (185830)
Policy (19398)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (2)
2024 Biotech Bay Standard (6)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (1736)
Accelerated approval (1)
Adcomms (8)
Allergies (65)
Alliances (26682)
ALS (47)
Alzheimer's disease (779)
Antibody-drug conjugate (ADC) (36)
Approvals (12276)
Artificial intelligence (144)
Autoimmune disease (6)
Automation (4)
Bankruptcy (140)
Best Places to Work (6893)
BIOSECURE Act (5)
Biosimilars (30)
Biotechnology (39)
Bladder cancer (39)
Brain cancer (15)
Breast cancer (155)
Cancer (1139)
Cardiovascular disease (94)
Career advice (406)
Career pathing (13)
CAR-T (58)
Cell therapy (178)
Cervical cancer (9)
Clinical research (40105)
Collaboration (376)
Compensation (95)
Complete response letters (8)
COVID-19 (1479)
CRISPR (10)
C-suite (103)
Cystic fibrosis (41)
Data (1174)
Decentralized trials (2)
Denatured (16)
Depression (25)
Diabetes (144)
Diagnostics (3473)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (44)
Drug pricing (52)
Drug shortages (20)
Duchenne muscular dystrophy (34)
Earnings (36471)
Editorial (17)
Employer branding (6)
Employer resources (44)
Events (51210)
Executive appointments (369)
FDA (13016)
Featured Employer (15)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (342)
Gene editing (30)
Generative AI (10)
Gene therapy (111)
GLP-1 (363)
Government (3008)
Grass and pollen (3)
Guidances (33)
Healthcare (12178)
Huntington's disease (9)
IgA nephropathy (12)
Immunology and inflammation (31)
Indications (17)
Infectious disease (1538)
Inflammatory bowel disease (76)
Inflation Reduction Act (4)
Influenza (21)
Intellectual property (38)
Interviews (40)
IPO (7030)
IRA (19)
Job creations (1837)
Job search strategy (378)
Kidney cancer (7)
Labor market (5)
Layoffs (161)
Leadership (3)
Legal (3625)
Liver cancer (52)
Lung cancer (190)
Lymphoma (74)
Machine learning (1)
Management (17)
Manufacturing (84)
MASH (38)
Medical device (12813)
Medtech (12816)
Mergers & acquisitions (10072)
Metabolic disorders (358)
Multiple sclerosis (40)
NASH (11)
Neurodegenerative disease (38)
Neuropsychiatric disorders (8)
Neuroscience (1041)
NextGen: Class of 2025 (3929)
Non-profit (2820)
Northern California (1119)
Now hiring (13)
Obesity (189)
Opinion (67)
Ovarian cancer (40)
Pain (52)
Pancreatic cancer (43)
Parkinson's disease (74)
Partnered (9)
Patents (83)
Patient recruitment (57)
Peanut (36)
People (34480)
Pharmaceutical (18)
Pharmacy benefit managers (11)
Phase I (11491)
Phase II (17370)
Phase III (14255)
Pipeline (449)
Podcasts (22)
Policy (43)
Postmarket research (1668)
Preclinical (3554)
Press Release (18)
Prostate cancer (61)
Psychedelics (17)
Radiopharmaceuticals (158)
Rare diseases (161)
Real estate (2840)
Recruiting (16)
Regulatory (14017)
Reports (16)
Research institute (1603)
Resumes & cover letters (48)
Rett syndrome (1)
RNA editing (1)
RSV (16)
Schizophrenia (41)
Series A (58)
Series B (36)
Service/supplier (3)
Sickle cell disease (20)
Southern California (967)
Special edition (3)
Sponsored (12)
Startups (2118)
Stomach cancer (7)
Supply chain (30)
The Weekly (6)
United States (10776)
Vaccines (319)
Venture capitalists (12)
Webinars (7)
Weight loss (129)
Women's health (16)
Worklife (4)
Date
Today (84)
Last 7 days (398)
Last 30 days (1583)
Last 365 days (19406)
2025 (3133)
2024 (19848)
2023 (22736)
2022 (30680)
2021 (32984)
2020 (32190)
2019 (28412)
2018 (21810)
2017 (18906)
2016 (18111)
2015 (21194)
2014 (16023)
2013 (13241)
2012 (14349)
2011 (14622)
2010 (13181)
Location
Africa (353)
Alabama (17)
Alaska (2)
Arizona (105)
Arkansas (9)
Asia (24347)
Australia (3856)
California (2518)
Canada (1067)
China (288)
Colorado (143)
Connecticut (150)
Delaware (89)
Europe (47512)
Florida (453)
Georgia (107)
Idaho (33)
Illinois (311)
India (11)
Indiana (197)
Iowa (2)
Japan (90)
Kansas (69)
Kentucky (12)
Louisiana (5)
Maine (26)
Maryland (558)
Massachusetts (1797)
Michigan (97)
Minnesota (242)
Mississippi (2)
Missouri (45)
Montana (18)
Nebraska (18)
Nevada (26)
New Hampshire (58)
New Jersey (922)
New Mexico (8)
New York (790)
North Carolina (503)
North Dakota (3)
Northern California (1119)
Ohio (115)
Oklahoma (3)
Oregon (23)
Pennsylvania (695)
Puerto Rico (4)
Rhode Island (18)
South America (519)
South Carolina (13)
Southern California (967)
Tennessee (61)
Texas (432)
Utah (97)
Virginia (64)
Washington D.C. (34)
Washington State (195)
West Virginia (3)
Wisconsin (33)
378,942 Results for "vivasure medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Vivasure Medical Announces First Large Hole Venous Patient Treated with PerQseal Elite Vascular Closure System
Vivasure Medical today announced it has treated the first large bore venous patient with the PerQseal ® Elite vascular closure system, a sutureless and fully bioresorbable large-bore vessel closure device.
April 15, 2024
·
3 min read
News
TCT 2024: Vivasure Medical to Unveil US Pivotal Data for PerQseal® Elite Vascular Closure System
October 21, 2024
·
3 min read
Vivasure Medical Announces 100th Patient Enrolled in U.S. Pivotal Study
Vivasure Medical® today announced it has enrolled the 100th patient in its PATCH Clinical Study, a multi-center, single-arm, pivotal study evaluating the safety and efficacy of the Vivasure PerQseal® Closure Device System.
November 14, 2023
·
2 min read
Vivasure Medical Announces First Patients Treated with PerQseal Elite Closure Device System
Vivasure Medical today announced the first patient treated with PerQseal ® Elite, the latest generation of the company’s fully absorbable large-hole closure system.
December 12, 2023
·
3 min read
Press Releases
Vivasure Announces Positive Results of PATCH IDE Pivotal Study Indicating Safety and Efficacy of PerQseal® Large Hole Closure Device
October 30, 2024
·
2 min read
Vivasure Medical Announces Enrollment of First Patients in Pivotal PATCH Study
Vivasure Medical®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced it has enrolled the first patients in the company’s PerQseal® PATCH Clinical Study, a multi-center, single-arm, pivotal study evaluating the safety and efficacy of the Vivasure PerQseal Closure Device System.
May 2, 2023
·
3 min read
FDA
Vivasure Medical Announces FDA IDE Approval to Initiate U.S. Pivotal Study
Vivasure Medical ® Limited today announced that the U.S. Food and Drug Administration (FDA) has granted an Investigational Device Exemption (IDE) to advance the company’s PATCH Clinical Study, a multi-center, single-arm, pivotal study evaluating the safety and effectiveness of the Vivasure PerQseal® Closure Device System.
March 13, 2023
·
4 min read
Vivasure Medical Announces First Patient Treated in U.S. Early Feasibility Study Evaluating PerQseal+
Vivasure Medical today announced that the first patient was treated in a U.S. early feasibility study evaluating PerQseal.
March 15, 2022
·
3 min read
Vivasure Medical Announces Series D Financing to Advance Portfolio of PerQseal Vessel Closure Devices
Vivasure Medical®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, announced the closing of the first tranche of €22 million as part of its Series D financing round that could reach up to €52 million in total.
May 17, 2022
·
3 min read
Vivasure Medical Announces Development of Sutureless Venous Closure Device for Use in Percutaneous Transcatheter Procedures
Vivasure Medical today announced its development program for PerQseal ® Blue, the company’s new investigational product.
July 15, 2021
·
3 min read
1 of 37,895
Next
